Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zui Zou
Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated With Cetuximab
Drugs in R and D
Pharmacology
Related publications
P2.01-35 Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Patients With Advanced Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab
British Journal of Cancer
Cancer Research
Oncology
Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib
Oncotarget
Oncology
Correction: Incidence and Risk of Hematologic Toxicities in Cancer Patients Treated With Regorafenib
Oncotarget
Oncology
Analysis of the Incidence of Cetuximab-Induced Hypomagnesemia in Patients With Oral Cancer
Japanese Journal of Oral and Maxillofacial Surgery
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Incidence and Relative Risk of Peripheral Neuropathy in Cancer Patients Treated With Eribulin: A Meta-Analysis
Oncotarget
Oncology
Correction To: Neutropenia Management With Palbociclib in Japanese Patients With Advanced Breast Cancer
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
The Risk and Predictors for Severe Radiation Pneumonitis in Lung Cancer Patients Treated With Thoracic Reirradiation
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology